Trademark Overview
On Friday, September 19, 2025, a trademark application was filed for NEOBIOMICS with the United States Patent and Trademark Office. The USPTO has given the NEOBIOMICS trademark a serial number of 79437559. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 27, 2025. This trademark is owned by Neobiomics AB. The NEOBIOMICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Food for babies; infant formula; food supplements; nutritional supplements; food supplements for non-medical purposes; vitamin supplements; dha algae oil dietary supplements; medicinal preparations and substances; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating sensory organ disorders; probiotic supplements; probiotic bacterial formulations for medical use; prebiotic supplements; dietary and nutritional supplements; protein dietary supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; bacterial preparations for medical purposes; pharmaceutical preparations for treating gastrointestinal disorders; medicines for the treatment of gastrointestinal diseases; all the aforementioned products intended for infants.
Medical and veterinary apparatus and instruments; examination, and monitoring equipment; intravenous feeding tubes; probes for medical purposes; feeding tubes; feeding aids and pacifiers; intravenous feeding bottles; feeding bottle teats; breast milk storage bottles; feeding bottles for food supplements and infant formula; apparatus, devices and articles for nursing infants; apparatus, devices and articles for nursing infants.
Science and technology services; research services; medical research; biomedical research services; research on the subject of pharmaceuticals; research relating to food supplements; medical research in the neonatal field; all of the foregoing excluding services in the field of oncology.
